Post-intestine transplant graft-vs-host disease associated with inclusion of a liver graft and with a high mortality risk

Jared W. Clouse, Chandrashekhar A. Kubal, Jonathan A. Fridell, E. Jordan Pearsall, Richard Mangus

Research output: Contribution to journalArticle

Abstract

Introduction: This study reports the incidence, anatomic location, and outcomes of graft-vs-host disease (GVHD) at a single active intestine transplant center. Methods: Records were reviewed for all patients receiving an intestine transplant from 2003 to 2015. Pathology reports and pharmacy records were reviewed to establish the diagnosis, location, and therapeutic interventions for GVHD. Results: A total of 236 intestine transplants were performed during the study period, with 37 patients (16%) developing GVHD. The median time to onset of disease was 83 days, with 89% of affected patients diagnosed in the first year post-transplant. Mortality for affected patients was 54% in the 1 year after GVHD diagnosis. Skin lesions were the most common manifestation of GVHD. Other sites of disease included lungs, bone marrow, oral mucosa, large intestine, and brain. The incidence of GVHD was 16% in adult patients, and slightly lower in pediatric recipients (13%). In adults, increasing graft volume (isolated vs multi-organ) and liver inclusion were associated with increasing risk of GVHD, though this was not seen in pediatric patients. Conclusion: Overall, 16% of intestine transplant recipients developed GVHD. GVHD is associated with high mortality, and disease in the lungs, brain, and bone marrow was universally fatal.

Original languageEnglish (US)
Article numbere13409
JournalClinical Transplantation
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Graft vs Host Disease
Intestines
Transplants
Mortality
Liver
Lung Diseases
Bone Marrow
Pediatrics
Large Intestine
Brain
Mouth Mucosa
Cohort Studies
Pathology
Skin
Incidence

Keywords

  • complications
  • graft-vs-host disease
  • intestine transplant
  • multivisceral transplant
  • outcomes

ASJC Scopus subject areas

  • Transplantation

Cite this

Post-intestine transplant graft-vs-host disease associated with inclusion of a liver graft and with a high mortality risk. / Clouse, Jared W.; Kubal, Chandrashekhar A.; Fridell, Jonathan A.; Pearsall, E. Jordan; Mangus, Richard.

In: Clinical Transplantation, 01.01.2018.

Research output: Contribution to journalArticle

@article{e896166443bf47a19d7822a241b03a0a,
title = "Post-intestine transplant graft-vs-host disease associated with inclusion of a liver graft and with a high mortality risk",
abstract = "Introduction: This study reports the incidence, anatomic location, and outcomes of graft-vs-host disease (GVHD) at a single active intestine transplant center. Methods: Records were reviewed for all patients receiving an intestine transplant from 2003 to 2015. Pathology reports and pharmacy records were reviewed to establish the diagnosis, location, and therapeutic interventions for GVHD. Results: A total of 236 intestine transplants were performed during the study period, with 37 patients (16{\%}) developing GVHD. The median time to onset of disease was 83 days, with 89{\%} of affected patients diagnosed in the first year post-transplant. Mortality for affected patients was 54{\%} in the 1 year after GVHD diagnosis. Skin lesions were the most common manifestation of GVHD. Other sites of disease included lungs, bone marrow, oral mucosa, large intestine, and brain. The incidence of GVHD was 16{\%} in adult patients, and slightly lower in pediatric recipients (13{\%}). In adults, increasing graft volume (isolated vs multi-organ) and liver inclusion were associated with increasing risk of GVHD, though this was not seen in pediatric patients. Conclusion: Overall, 16{\%} of intestine transplant recipients developed GVHD. GVHD is associated with high mortality, and disease in the lungs, brain, and bone marrow was universally fatal.",
keywords = "complications, graft-vs-host disease, intestine transplant, multivisceral transplant, outcomes",
author = "Clouse, {Jared W.} and Kubal, {Chandrashekhar A.} and Fridell, {Jonathan A.} and Pearsall, {E. Jordan} and Richard Mangus",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/ctr.13409",
language = "English (US)",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Post-intestine transplant graft-vs-host disease associated with inclusion of a liver graft and with a high mortality risk

AU - Clouse, Jared W.

AU - Kubal, Chandrashekhar A.

AU - Fridell, Jonathan A.

AU - Pearsall, E. Jordan

AU - Mangus, Richard

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: This study reports the incidence, anatomic location, and outcomes of graft-vs-host disease (GVHD) at a single active intestine transplant center. Methods: Records were reviewed for all patients receiving an intestine transplant from 2003 to 2015. Pathology reports and pharmacy records were reviewed to establish the diagnosis, location, and therapeutic interventions for GVHD. Results: A total of 236 intestine transplants were performed during the study period, with 37 patients (16%) developing GVHD. The median time to onset of disease was 83 days, with 89% of affected patients diagnosed in the first year post-transplant. Mortality for affected patients was 54% in the 1 year after GVHD diagnosis. Skin lesions were the most common manifestation of GVHD. Other sites of disease included lungs, bone marrow, oral mucosa, large intestine, and brain. The incidence of GVHD was 16% in adult patients, and slightly lower in pediatric recipients (13%). In adults, increasing graft volume (isolated vs multi-organ) and liver inclusion were associated with increasing risk of GVHD, though this was not seen in pediatric patients. Conclusion: Overall, 16% of intestine transplant recipients developed GVHD. GVHD is associated with high mortality, and disease in the lungs, brain, and bone marrow was universally fatal.

AB - Introduction: This study reports the incidence, anatomic location, and outcomes of graft-vs-host disease (GVHD) at a single active intestine transplant center. Methods: Records were reviewed for all patients receiving an intestine transplant from 2003 to 2015. Pathology reports and pharmacy records were reviewed to establish the diagnosis, location, and therapeutic interventions for GVHD. Results: A total of 236 intestine transplants were performed during the study period, with 37 patients (16%) developing GVHD. The median time to onset of disease was 83 days, with 89% of affected patients diagnosed in the first year post-transplant. Mortality for affected patients was 54% in the 1 year after GVHD diagnosis. Skin lesions were the most common manifestation of GVHD. Other sites of disease included lungs, bone marrow, oral mucosa, large intestine, and brain. The incidence of GVHD was 16% in adult patients, and slightly lower in pediatric recipients (13%). In adults, increasing graft volume (isolated vs multi-organ) and liver inclusion were associated with increasing risk of GVHD, though this was not seen in pediatric patients. Conclusion: Overall, 16% of intestine transplant recipients developed GVHD. GVHD is associated with high mortality, and disease in the lungs, brain, and bone marrow was universally fatal.

KW - complications

KW - graft-vs-host disease

KW - intestine transplant

KW - multivisceral transplant

KW - outcomes

UR - http://www.scopus.com/inward/record.url?scp=85057744781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057744781&partnerID=8YFLogxK

U2 - 10.1111/ctr.13409

DO - 10.1111/ctr.13409

M3 - Article

C2 - 30222903

AN - SCOPUS:85057744781

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

M1 - e13409

ER -